EUVIMEDEUVIMED entdecken
Crossref

For adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who are stable on intravenous immunoglobulin (IVIg), how does switching to subcutaneous immunoglobulin (SCIg) maintenance treatment compare with placebo?

Agustín Ciapponi

Cochrane Clinical Answers · 09.11.2026

DOI: 10.1002/cca.4884 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cochrane Clinical Answers, online erschienen am 09.11.2026. Verfasst von Agustín Ciapponi. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ciapponi, A. (2026). For adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who are stable on intravenous immunoglobulin (IVIg), how does switching to subcutaneous immunoglobulin (SCIg) maintenance treatment compare with placebo?. Cochrane Clinical Answers. https://doi.org/10.1002/cca.4884

Vancouver

Ciapponi A. For adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who are stable on intravenous immunoglobulin (IVIg), how does switching to subcutaneous immunoglobulin (SCIg) maintenance treatment compare with placebo?. Cochrane Clinical Answers. 2026. doi:10.1002/cca.4884

BibTeX
@article{Ciapponi2026,
  author = {Ciapponi, Agustín},
  title = {For adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who are stable on intravenous immunoglobulin (IVIg), how does switching to subcutaneous immunoglobulin (SCIg) maintenance treatment compare with placebo?},
  journal = {Cochrane Clinical Answers},
  year = {2026},
  doi = {10.1002/cca.4884}
}
Kostenlos starten →